What are synthetic drugs?
New, synthetic versions of harmful drugs, including synthetic opioids and synthetic cannabinoids, are increasingly found in UK’s illegal drug markets.

This pack has been prepared ahead of the debate to be held in the Commons Chamber on Thursday 19 April 2018 on surgical mesh. The subject for the debate has been selected by the Backbench Business Committee and the debate will be opened by Emma Hardy MP.
Commons Library debate pack - Surgical mesh (175 KB , PDF)
The motion to be debated is:
That this House commends the recent announcement of a retrospective audit into surgical mesh for pelvic organ prolapse and stress urinary incontinence; notes that vaginal mesh has been banned in other jurisdictions such as New Zealand; further notes that NICE guidance recommends against the use of surgical mesh for pelvic organ prolapse and that no NICE recommendations have been made for stress urinary incontinence; reports that Sheffield University recently announced the development of a new mesh material and calls on the Government to suspend prolapse and incontinence mesh operations while the audit is being carried out, bring forward the NICE guidelines for mesh in stress related urinary incontinence from 2019 to 2018, and to commit to a full public inquiry into mesh if the audit suggessts that this is the best course of action.
Commons Library debate pack - Surgical mesh (175 KB , PDF)
New, synthetic versions of harmful drugs, including synthetic opioids and synthetic cannabinoids, are increasingly found in UK’s illegal drug markets.
An overview of the current system of support for children and young people with special educational needs, and pressure on the system. Updated with new 2024-25 SEND incidence and EHC plan data
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.